| RS80159221 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS80163539 |
ASPH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS80164537 |
TRPC4
|
Health Risk |
Pathogenic |
Autism, susceptiblity to |
| RS80164898 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS80166001 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS80168454 |
PTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Basal cell carcinoma |
| RS80181772 |
ABCA12
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4B |
| RS80187739 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS80191629 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome 11 |
| RS80199741 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS80201355 |
PRPF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, PRPF3-related disorder |
| RS80203202 |
HERC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Macrocephaly, dysmorphic facies |
| RS80207011 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Mitochondrial complex II deficiency |
| RS80214209 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS80222298 |
GBA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS80224512 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS80224560 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Hereditary pancreatitis |
| RS80227512 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Susceptibility to mononeuropathy of the median nerve |
| RS80227749 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS80232004 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 2, Aortic valve disease 2 |
| RS80233027 |
PIK3R2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome |
| RS80236571 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hirschsprung disease, susceptibility to |
| RS80239443 |
CEP152
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 9, primary |
| RS80256822 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Papillary renal cell carcinoma type 1 |
| RS80258644 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS80258959 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group D2 |
| RS80265967 |
SCAF4;SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis 1 |
| RS80266334 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS80267624 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS80272723 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS80277041 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS80277939 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS80282562 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, ivacaftor response - Efficacy |
| RS8028305 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Congenital hypothyroidism |
| RS80293130 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chromosome 2p16.3 deletion syndrome, Pitt-Hopkins-like syndrome 2 |
| RS80296256 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS80297647 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, PAH-related disorder |
| RS80299691 |
LBR
|
Health Risk |
Conflicting classifications of pathogenicity |
Greenberg dysplasia, Connective tissue disorder |
| RS80311498 |
SCNN1B
|
Health Risk |
Likely pathogenic |
— |
| RS80315385 |
CACNA1C
|
Health Risk |
Pathogenic |
Timothy syndrome, Congenital long QT syndrome |
| RS80326661 |
POMC
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity, POMC-related disorder |
| RS80330850 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Leprechaunism syndrome, Rabson-Mendenhall syndrome |
| RS80337021 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, idiopathic generalized |
| RS80338642 |
LYST
|
Health Risk |
Pathogenic |
CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE |
| RS80338643 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE |
| RS80338644 |
LYST
|
Health Risk |
Pathogenic |
CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE |
| RS80338645 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS80338646 |
LYST
|
Health Risk |
Pathogenic |
CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE |
| RS80338647 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS80338649 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, CHEDIAK-HIGASHI SYNDROME |
| RS80338651 |
LYST
|
Health Risk |
Pathogenic |
CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE |
| RS80338652 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
CHEDIAK-HIGASHI SYNDROME, ADULT TYPE |
| RS80338655 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS80338658 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS80338660 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS80338664 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS80338667 |
LYST
|
Health Risk |
Pathogenic |
CHEDIAK-HIGASHI SYNDROME, CHILDHOOD TYPE |
| RS80338668 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS80338669 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, LYST-related disorder |
| RS80338671 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IV, nonprogressive hepatic |
| RS80338672 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IV, classic hepatic |
| RS80338673 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IV, combined hepatic and myopathic |
| RS80338675 |
PRPS1
|
Health Risk |
Pathogenic |
Arts syndrome, Arts syndrome |
| RS80338677 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Inborn genetic diseases |
| RS80338678 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS80338679 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS80338680 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Inborn genetic diseases |
| RS80338681 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, MAN2B1-related disorder |
| RS80338682 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Familial spontaneous pneumothorax |
| RS80338684 |
BTD
|
Health Risk |
Pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS80338685 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Intellectual disability |
| RS80338686 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Inborn genetic diseases |
| RS80338688 |
SOX9
|
Health Risk |
Pathogenic |
CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL, Camptomelic dysplasia |
| RS80338694 |
CDAN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Anemia, congenital dyserythropoietic |
| RS80338696 |
CDAN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital dyserythropoietic anemia, type I |
| RS80338697 |
CDAN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital dyserythropoietic anemia, type I |
| RS80338699 |
CDAN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital dyserythropoietic anemia, type I |
| RS80338700 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, 6 conditions |
| RS80338701 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, Inborn genetic diseases |
| RS80338702 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS80338703 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, Congenital cerebellar hypoplasia |
| RS80338704 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS80338706 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, Inborn genetic diseases |
| RS80338707 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS80338708 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, See cases |
| RS80338709 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, Inborn genetic diseases |
| RS80338710 |
ARSL
|
Health Risk |
Likely pathogenic |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS80338711 |
ARSL
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS80338714 |
ARSL
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked chondrodysplasia punctata 1, See cases |
| RS80338715 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Neonatal intrahepatic cholestasis due to citrin deficiency, Citrin deficiency |
| RS80338716 |
SLC25A13
|
Health Risk |
Pathogenic |
Neonatal intrahepatic cholestasis due to citrin deficiency, Citrin deficiency |
| RS80338717 |
SLC25A13
|
Health Risk |
Pathogenic |
Neonatal intrahepatic cholestasis due to citrin deficiency, Citrullinemia type II |
| RS80338718 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrullinemia |
| RS80338719 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrullinemia type II, Neonatal intrahepatic cholestasis due to citrin deficiency |
| RS80338720 |
SLC25A13
|
Health Risk |
Pathogenic |
Neonatal intrahepatic cholestasis due to citrin deficiency, Citrin deficiency |
| RS80338721 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Citrullinemia type II |
| RS80338722 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrullinemia type II, Neonatal intrahepatic cholestasis due to citrin deficiency |
| RS80338723 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrullinemia type II, Citrin deficiency |
| RS80338724 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Neonatal intrahepatic cholestasis due to citrin deficiency, Citrin deficiency |
| RS80338725 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrullinemia type II, Citrullinemia |